<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>hyperparathyroidism &#8211; mikrobik.net</title>
	<atom:link href="https://wp.mikrobik.net/tag/hyperparathyroidism/feed/" rel="self" type="application/rss+xml" />
	<link>https://wp.mikrobik.net</link>
	<description></description>
	<lastBuildDate>Wed, 25 Jun 2025 11:31:36 +0000</lastBuildDate>
	<language>tr</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.1</generator>
	<item>
		<title>Primary hyperparathyroidism and familial hyperparathyroid syndromes</title>
		<link>https://wp.mikrobik.net/primary-hyperparathyroidism-and-familial-hyperparathyroid-syndromes/</link>
		
		<dc:creator><![CDATA[mikrobik]]></dc:creator>
		<pubDate>Wed, 10 Nov 2010 01:35:00 +0000</pubDate>
				<category><![CDATA[Biyokimya Derlemeleri]]></category>
		<category><![CDATA[hyperparathyroidism]]></category>
		<guid isPermaLink="false"></guid>

					<description><![CDATA[Primary hyperparathyroidism and familial hyperparathyroid syndromes. Blackburn M, Diamond T. Aust Fam Physician. 2007 Dec;36(12):1029-33. BACKGROUND: Ninety percent of cases of hypercalcaemia are due to primary hyperparathyroidism or hypercalcaemia of malignancy. OBJECTIVE: This...]]></description>
										<content:encoded><![CDATA[<p><strong><span style="color:#5C3566;">Primary hyperparathyroidism and familial hyperparathyroid syndromes.</span></strong><br />
Blackburn M, Diamond T.</p>
<p><a href="http://www.racgp.org.au/afpbackissues/2007/200712/200712Blackburn.pdf" target="_blank" rel="noopener">Aust Fam Physician. 2007 Dec;36(12):1029-33.</a></p>
<p>BACKGROUND: Ninety percent of cases of hypercalcaemia are due to primary hyperparathyroidism or hypercalcaemia of malignancy.</p>
<p>OBJECTIVE: This article outlines the diagnostic features of primary hyperparathyroidism and determines who would benefit from parathyroidectomy. It also aims to raise awareness of familial hyperparathyroid syndromes.</p>
<p>DISCUSSION: Diagnosis of primary hyperparathyroidism requires hypercalcaemia, elevated or inappropriately normal serum parathyroid hormone and a fractional urinary excretion of calcium greater than 0.02. Many patients benefit from parathyroidectomy, which has a high rate of cure.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Secondary Hyperparathyroidism: Pathophysiology and Treatment</title>
		<link>https://wp.mikrobik.net/secondary-hyperparathyroidism-pathophysiology-and-treatment/</link>
		
		<dc:creator><![CDATA[mikrobik]]></dc:creator>
		<pubDate>Fri, 25 Dec 2009 10:52:00 +0000</pubDate>
				<category><![CDATA[Biyokimya Derlemeleri]]></category>
		<category><![CDATA[hyperparathyroidism]]></category>
		<guid isPermaLink="false"></guid>

					<description><![CDATA[Secondary Hyperparathyroidism: Pathophysiology and Treatment Wissam Saliba, Boutros El-Haddad The Journal of the American Board of Family Medicine 22 (5): 574-581 (2009) Secondary hyperparathyroidism is a frequently encountered problem in the management of...]]></description>
										<content:encoded><![CDATA[<p><strong><span style="color:#5C3566;">Secondary Hyperparathyroidism: Pathophysiology and Treatment</span></strong><br />
Wissam Saliba, Boutros El-Haddad</p>
<p><a href="http://www.jabfm.org/cgi/reprint/22/5/574" target="_blank" rel="noopener">The Journal of the American Board of Family Medicine 22 (5): 574-581 (2009)</a> </p>
<p>Secondary hyperparathyroidism is a frequently encountered problem in the management of patients with chronic kidney disease (CKD). Its pathophysiology is mainly due to hyperphosphatemia and vitamin D deficiency and resistance. This condition has a high impact on the mortality and morbidity of dialysis patients. Early diagnosis of secondary hyperparathyroidism is crucial in the management of patients with CKD. The treatment remains a challenge for patients and their clinicians. It should include a combination of dietary phosphorus restriction, phosphate binders, vitamin D analogues, and calcimimetics. </p>
<p><img decoding="async" src="http://www.jabfm.org/content/vol22/issue5/images/medium/zkb0050930610001.gif" alt="" style="max-width:100%;height:auto;" /></p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
